Kevin Petrecca
Werke:
- Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
- Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis
- Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis